Rajesh Kumar Kainthan

USPTO Granted Patents = 24 (Patent Applications = 10)

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 7 (Patent Applications = 14)

Average Co-Inventor Count = 5.8

ph-index = 7

Forward Citations = 131(Granted Patents)

Location History:

Burnaby, CA (2016)
Cambridge, MA (US) (2017)
Tappan, NY (US) (2015 - 2024)

Company Filing History:

University of British Columbia

patents

4 out of 5

Centre for Drug Research and Development

patents

4. 1 out of 57

Arbutus Biopharma Corporation

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12343389 - capsular polysaccharides and conjugates thereof (2025-07-01),

2. 12234259 - Glycoconjugation process (2025-02-25),

3. 11872274 - Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof (2024-01-16),

4. 11707529 - Immunogenic glycoprotein conjugates (2023-07-25),

5. 11603384 - Glycoconjugation process (2023-03-14),

6. 11426456 - [object Object] (2022-08-30),

7. 11160855 - Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof (2021-11-02),

8. 11117928 - Glycoconjugation process (2021-09-14),

9. 11090375 - Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof (2021-08-17),

10. 10946086 - Group Bpolysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof (2021-03-16),

11. 10918708 - capsular polysaccharides and conjugates thereof (2021-02-16),

12. 10745438 - Glycoconjugation process (2020-08-18),

13. 10668164 - Immunogenic glycoprotein conjugates (2020-06-02),

14. 10525131 - Derivatized hyperbranched polyglycerols (2020-01-07),

15. 10392420 - Glycoconjugation process (2019-08-27),

Title: The Innovative Mind of Rajesh Kumar Kainthan

Introduction: Rajesh Kumar Kainthan, based in Tappan, NY, is a notable inventor with a remarkable portfolio of 22 patents. His groundbreaking work predominantly focuses on immunogenic compositions and glycoconjugation processes, demonstrating his commitment to advancing medical science and public health.

Latest Patents: Among his latest innovations is a patent for the "Glycoconjugation process," which involves methods for preparing glycoconjugates that combine saccharides with carrier proteins using stable nitroxyl radicals as oxidizing agents. This patent contributes to the development of immunogenic compositions featuring glycoconjugates for potential use in vaccines. Another significant patent is for "Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof." This invention introduces novel immunogenic compositions that contain glycoconjugates from serotypes not included in existing vaccines such as PREVNAR® and SYNFLORIX®, thus broadening the possibilities for vaccination against pneumococcal infections in vulnerable populations including infants and the elderly.

Career Highlights: Rajesh has had an illustrious career, having worked with prominent organizations such as Pfizer Corporation and the University of British Columbia. His experience at these institutions has significantly contributed to his expertise in research and innovation in the field of immunology.

Collaborations: Throughout his career, Rajesh Kumar Kainthan has collaborated with talented individuals, including Avvari Krishna Prasad and Jin-Hwan Kim. These collaborations reflect a collective effort towards advancing research and creating impactful innovations in health sciences.

Conclusion: Rajesh Kumar Kainthan stands out in the realm of invention with his substantial contributions to immunology and vaccine development. His innovative patents are poised to play a pivotal role in enhancing public health initiatives and combating infectious diseases.

This text is generated by artificial intelligence and may not be accurate.